Effect of Individualised Homoeopathic Medicines on the Management of Ganglion: A Prospective, Single Arm, Open label, Interventional Trial - NI

The Calcutta Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1. Patients of irrespective of their gender including transgender, age between18-65 will
•be taken into consideration, whoever has ganglion in any part of the body.
•2. Clinically diagnosed cases of ganglion.
•3. Any ganglion that recurred after 6 months of surgical excision/re-excision.
•4. Patients who have not taken any treatment for ganglion in past 4 weeks.
•5. Literate patients who can read Bengali and/or English and /or Hindi
•6. Providing the written informed consent to participate in the interventional trial.

•1. Occult ganglion for which MRI is needed for confirmatory diagnosis.
•2. In doubtful cases radiographic examination will be done and will be excluded if
•found otherwise.
•3. Patients who are unwilling to give informed consent.
•4. Patients suffering from any systemic illness and taking conventional medicine for
•5. Pregnant and lactating mothers will be excluded.
•6. Patients who are being immune-compromised.
•7. Substance abuse and/or severely dependent on that.
•8. Undergoing homoeopathic treatment for any other illness within last 4 weeks.

发起方

The Calcutta Homoeopathic Medical College and Hospital